Dr. Jürgen Rockstroh, is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn in Germany. He earned a Doctor of Medicine degree from the Rheinische Friedrich-Wilhelms University of Bonn, and completed his residency in the Department of Medicine also at the University of Bonn. His department treats the world’s largest cohort of HIV-infected hemophiliacs. In addition to his clinical practice, Dr. Rockstroh is involved in HIV research on: antiretroviral therapy, including new drug classes; the course of HIV disease in hemophiliacs; and HIV and hepatitis co-infection. More recently, he has also started working on the impact of COVID-19 as well as Mpox on HIV-coinfection. He has been an investigator in multiple clinical trials of antiretroviral agents and treatments for HIV, hepatitis co-infection and COVID-19. Since 2009 he has been a member of the executive committee of the European AIDS Clinical Society (EACS). Since 2023 he is the EACS guidelines chair.
At the completion of this educational activity learners will:
1. Become familiar with the current HIV epidemiology in Europe.
2. Understand the challenges around HIV care in migrant populations and war refugees
3. Be aware of new data on antiretroviral therapy in HIV.
4. Know about new cohort research on aging in HIV and impact of HIV frequency and severity of underlying comorbidities.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Kristen Marks (Moderator) has no relevant financial relationships to disclose.
- Dr. Jürgen Rockstroh (Presenter) has had the following relevant financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Advisor to Abbvie, Gilead, Merck, and ViiV; Speaker for Gilead, Merck, Janssen, and ViiV; Consultant to Boehringer. Dr. Rockstroh submitted his slides in advance for adequate peer review and supported his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships were mitigated.